Skip to main content
. 2019 Apr 22;14(4):e0215894. doi: 10.1371/journal.pone.0215894

Fig 6. Trastuzumab treatment together with miR-770-5p modulates AKT and ERK expression level.

Fig 6

miR-770-5p mimic was transfected to BT-474 cells and; total and phoshorylated AKT and ERK protein levels were analyzed by Western blot 72 h after transfection. Combination of trastuzumab with miR-770-5p mostly affected pERK and pAKT levels in BT-474 cells (n = 3, *p<0.05).